The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000 Ventilator associated pneumonia in the era of COVID 19 pandemic: How common and what is the impact? Critical Care Springer Nature Link Pharma's New Frontier How the VAP Market is Shaping the Future of Critical Care Automated secretion management system to reduce VAP cases in hospitals VAP Diagnosing and Managing Ventilator Associated Pneumonia